[amazon_link asins=’B001G8Y9XO,B004LODJYK,B0186J6JGA,1615190805′ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’093225a5-535b-11e7-837e-bf5270062407′]
[amazon_link asins=’B00BF1NCM6,B00NI9FK5K,B008RMHED4,B00LIFN6FC’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’3e2794b9-535b-11e7-b36a-2bcd5e7bb224′]
This gives a potential new target for developing treatments and even a vaccine, they believe.
Coeliac disease is caused by an intolerance to gluten found in foods like bread, pasta and biscuits.
It is thought to affect around 1 in every 100 people in the UK, particularly women.
The link between gluten and coeliac disease was first established 60 years ago but scientists have struggled to pinpoint the precise component in gluten that triggers it.
The research, published in the journal, Science Translational Medicine, studied 200 patients with coeliac disease attending clinics in Oxford and Melbourne.
The volunteers were asked to eat bread, rye muffins or boiled barley. Six days later they had blood samples taken to measure their immune response to thousands of different gluten fragments, or peptides.
The tests identified 90 peptides that caused some level of immune reaction, but three were found to be particularly toxic.
Professor Bob Anderson, head of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, said: “These three components account for the majority of the immune response to gluten that is observed in people with coeliac disease.”
Coeliac disease can be managed with a gluten-free diet but this is often a challenge for patients. Nearly half still have damage to their intestines five years after starting a gluten-free diet.
Professor Anderson said one potential new therapy is already being developed, using immunotherapy to expose people with coeliac disease to tiny amounts of the three toxic peptides.
Early results of the trial are expected in the next few months.
Sarah Sleet, Chief Executive of the charity Coeliac UK, said the new finding could potentially help lead to a vaccine against coeliac disease but far more research was needed.
She said: “It’s an important piece of the jigsaw but a lot of further work remains so nobody should be expecting a practical solution in their surgery within the next 10 years.”
The symptoms of coeliac disease vary from person to person and can range from very mild to severe.
Some symptoms may be mistaken as irritable bowel syndrome or wheat intolerance.
*Continue reading the main story Coeliac disease is an autoimmune disease
*Gluten found in wheat, barley and rye triggers an immune reaction in people with coeliac disease
*This damages the lining of the small intestine
*Other parts of the body may be affected
Source: Coeliac UK
You may click to see:-
Coeliac bone loss link uncovered
Hotel Babylon star on coeliac disease
Related articles by Zemanta
- Toxic trio identified as the basis of celiac disease (eurekalert.org)
- Study Points to Molecular Origins of Celiac Disease (health.usnews.com)
- Celiac disease culprits found (cbc.ca)
- Study Points to Molecular Origins of Celiac Disease (nlm.nih.gov)
- Fragments of Gluten that Trigger Celiac Disease Isolated (neatorama.com)